Ummid Assistant

Mumbai NGO, top experts join hands to train students for civil services exams

Welcome Guest! You are here: Home » Health

Synthetic drug shows promise in brain cancer

Wednesday September 26, 2012 10:36:17 PM, IANS

Washington: Researchers led by an Indian-origin investigator are testing the suitability of a synthetic cannabinoid drug - dexanabinol - for curing brain cancer. Preliminary tests show that it kills cultured cancer cells derived from many tumour types, a US report says.

Additional research in Santosh Kesari's neuro-oncology lab at the University of California San Diego Moores Cancer Center, demonstrated the drug's anti-cancer effects in patient-derived brain cancer cell lines. Kesari is the principal study-investigator.

It could be given as a weekly intravenous infusion. More recently, researchers at e-Therapeutics, the study sponsor, showed that dexanabinol (ETS2101) kills cultured cancer cells derived from many tumour types.

"In this Phase I study, we are examining the safety of multiple doses of dexanabinol, extent of penetration into the brain, and suitability for future trials. What we hope to determine is the safe and optimal dose of drug in the brain," said Kesari, according to a California statement.

Dexanabinol is a cannabinoid derivative that causes no psychotropic (altering perception or behaviour) effects. It was tested previously as a neuro-protective in patients with traumatic brain injury. During these trials the drug was found to cross the blood-brain barrier.

The blood-brain barrier has been defined by The Free Dictionary "as a physiological mechanism that alters the permeability of brain capillaries so that certain drugs are prevented from entering brain tissue, while other substances are allowed to enter freely."

Dexanabinol's potential in fighting cancer was identified through a new approach to drug discovery called network pharmacology, a way to analyze the network of proteins underlying a disease process.

Network pharmacology enables scientists to seek drugs from among existing compounds, or design new molecules, that act simultaneously on a number of individual proteins to disrupt the cancer-susceptible network.


 


 


 

 

 

Home | Top of the Page

Comments

Note: By posting your comments here you agree to the terms and conditions of www.ummid.com

Comments powered by DISQUS

i

i

 

More Headlines

Catholics protest their portrayal in Bollywood films

India's first private airport to come up in Kerala

Google brain teasers test your job skills

Your demands won't be met, Nitish tells teachers

Will back central, Maharashtra government: Pawar

8 students killed, 30 injured in train-bus crash

Walmart to launch first Indian store in 18 months

Bharti Walmart to open six wholesale stores this fiscal

Rolls-Royce to have showrooms in three more Indian cities

Retired cops push for police reforms, launch movement

UP to have anti-obscene call cell in each district

Muslim world leaders reject Obama's free speech rhetoric at UN

 

Top Stories

Muslim world leaders reject Obama's free speech rhetoric at UN

Muslim leaders demanded international action to stop religious insults in a challenge to U.S. President Barack Obama’s defense of freedom of expression at the U.N. General Assembly  »

'Why Holocaust deniers frowned upon and Islam bashers protected?'

Why The Prophet is being targeted?

 

  Most Read

Bharti Walmart to open six wholesale stores this fiscal

Bharti Walmart, the joint venture between Bharti Enterprises and Walmart Stores Inc, plans to open six more Best  »

Walmart to launch first Indian store in 18 months

Will India and China fight a war again?

Most Indians rightly see the 1962 war between India and China, and a relatively small military defeat and the major national panic that followed, as a cathartic event. While 1962 will still be the seminal year for Sino-Indian relations, it is in 1967  »

'India must prepare for conventional wars with Pakistan, China'

 

  News Pick

Only barrier-free schools will retain recognition: Court

The Delhi High Court has directed the government to de-recognise private schools which do not appoint special educators for children with disabilities and make their premises barrier-free. The court, in a recent  »

Degrees out of reach for 150,000 distance education students

Nearly 150,000 students face an uncertain future after the Haryana government directed the Maharshi Dayanand University (MDU) in Rohtak to shut down its more than 11,000 study centres inside and outside the state.  »

Pakistani youth clean up violence-hit areas

"Even in this pall of night, there is light", a Pakistani daily said Tuesday after young men and women in Karachi, Lahore and Islamabad armed themselves with brooms, paint and brushes to clean up areas hit by  »

Suriya Mandir 'comes' from Gwaliar to Malegaon

Unlike the tradition at other places in Maharashtra, the Ganesh decoration in Malegaon is observed only on the evening before the final immersion day. However Ekta Mandal which turns  »

 

Picture of the Day

Prime Minister Dr. Manmohan Singh and President of the Palestine National Authority Mahmoud Abbas at the delegation level talks, in New Delhi on September 11, 2012.

 

 
 
 
 
 
 
 
 

RSS  |  Contact us

 

| Quick links

News

 

Subscribe to

Ummid Assistant

 

National

Science & Technology

RSS

Scholarships

About us

International

Health

Twitter

Government Schemes

Feedback

Regional

History

Facebook

Education

Register

Politics

Opinion

Newsletter

Contact us

Business

Career

Education

     

 

 

Ummid.com: Disclaimer | Terms of Use | Advertise with us | Link Exchange

Ummid.com is part of the Awaz Multimedia & Publications providing World News, News Analysis and Feature Articles on Education, Health. Politics, Technology, Sports, Entertainment, Industry etc. The articles or the views displayed on this website are for public information and in no way describe the editorial views. The users are entitled to use this site subject to the terms and conditions mentioned.

© 2012 Awaz Multimedia & Publications. All rights reserved.